Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1
Advanced Science · 2025
DOI: 10.1002/advs.202510597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Linyi Hu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: Oncolytic Viruses, Receptors, Virus, Oncolytic Virotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Viral receptors are essential host factors that determine the tropism of oncolytic viruses, and contribute to their selective targeting of cancer cells. In this study, a membrane protein‐targeted CRISPR‐Cas9 screen is conducted and identify transmembrane protein adipocyte‐associated 1 (TPRA1) as a novel receptor for oncolytic virus M1(OVM), a promising oncolytic virus currently under clinical investigation. Mechanistically, TPRA1 facilitates OVM infection by promoting both viral attachment and internalization. Extracellular region of TPRA1 directly binds OVM particles via glycosylation, while its cytoplasmic tail mediates virus endocytosis, collectively enabling efficient viral entry and cancer cell lysis. Importantly, TPRA1 expression in cell lines, mouse models, and patient‐derived tumor samples are positively correlated with their respective sensitivity to OVM, and TPRA1 is upregulated in a high proportion of tumors compared to adjacent normal tissues, highlighting its potential as a therapeutic response biomarker. Furthermore, TPRA1 also promotes the entry of Semliki Forest Virus, suggesting its conserved role in alphavirus infection. Together, these findings establish TPRA1 as both a mechanistic determinant of OVM tropism and a biomarker to guide patient selection in clinical trials of OVM‐based therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
- Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
- Guangmei Yan, Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
- School of Life Sciences, Peking University, Beijing, 100871, China.
- The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655, China.
- The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
ORCID-Profile: Jiankai Liang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Project of Guangzhou City
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Hu, L., Zhang, G., Lin, Y., Yi, S., Yang, J., Lin, X., Song, D., Liu, Z., Zhang, J., Zeng, Y., Huang, S., Fan, Z., Zhang, J., Liu, Y., Hu, C., Zhu, W., Yin, W., Hu, J., Yan, G., …, & Liang, J. (2025). Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1. Advanced Science. https://doi.org/10.1002/advs.202510597
Vancouver
Hu L, Zhang G, Lin Y, Yi S, Yang J, Lin X, et al. Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1. Advanced Science. 2025. doi:10.1002/advs.202510597
BibTeX
@article{Hu2025,
author = {Hu, Linyi and Zhang, Guigen and Lin, Yuan and Yi, Shiming and Yang, Jingyu and Lin, Xueying and Song, Deli and Liu, Zhiheng and Zhang, Jiayu and Zeng, Ying and Huang, Shanyu and Fan, Zhen and Zhang, Jifu and Liu, Ying and Hu, Cheng and Zhu, Wenbo and Yin, Wei and Hu, Jun and Yan, Guangmei and Cai, Jing and Liang, Jiankai},
title = {Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202510597}
}
EUVIMED